Hybrid Public Workshop on AI in Drug and Biological Product Development

Webinars | August 22, 2024

Topics Included: Artificial Intelligence

SHARE TO:

Hybrid Public Workshop Resources:

Full Agenda

Download full PowerPoint slide set

Hybrid Public Workshop Speakers, Moderators, & Panelists (in order of appearance):

Morgan Hanger, Clinical Trials Transformation Initiative
Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research (CDER), United States
Food and Drug Administration (FDA)
Tala Fakhouri, Associate Director for Data Science and Artificial Intelligence Policy, CDER, FDA
Anindita Saha, Associate Director for Strategic Initiatives, Digital Health Center of Excellence
(DHCoE), Center for Devices and Radiological Health (CDRH), FDA
Elazer Edelman, Edward J. Poitras Professor in Medical Engineering and Science, and Director,
Institute of Medical Engineering and Science, Massachusetts Institute of Technology (MIT)
Sam Glassenberg, Founder & CEO, Level Ex
Charles Fisher, CEO, Unlearn.AI
Stephen Pyke, Chief Clinical Data & Digital Officer and Executive Vice President, Parexel;
Chair, AI/ML Committee, ACRO
Marsha Samson, Senior Analyst, CDER, FDA
Ittai Dayan, Co-Founder & CEO, Rhino Health
Merage Ghane, Principal Behavioral Designer, ideas42
Wade Davis, Vice President, Computational Science, Moderna
Hussein Ezzeldin, Senior Digital Health Expert, Office of Biostatistics and Pharmacovigilance
(OBPV), CDER, FDA
Artem Trotsyuk, AI Ethics and Policy Research Fellow, Stanford University
Luca Emili, Founder & CEO, InSilicoTrials
Michael Lingzhi Li, Assistant Professor, Technology and Operations Management Unit,
Harvard Business School
Subha Madhavan, Head of Clinical AI/ML & Digital Sciences, Pfizer
Scott Steele, Senior Advisor for Translational Science, Center for Biologics Evaluation and
Research (CBER), FDA
Dina Katabi, Thuan and Nicole Pham Professor of Electrical Engineering and Computer
Science, and Director, Center for Wireless Networks and Mobile Computing, MIT
Andrew Bate, Vice President & Head of Safety Innovation & Analytics, GSK
Ryan Hoshi, Director, Regulatory Policy & Intelligence, AbbVie
Nicole Mahoney, Executive Director, Regulatory Policy, and Global Regulatory Policy Lead,
Data and Digital Technologies, Novartis
Hesha Jani Duggirala, Senior Epidemiologist, Center for Veterinary Medicine (CVM), FDA
Qi Liu, Associate Director for Innovation & Partnership in the Office of Clinical Pharmacology
(OCP)/ Office of Translational Sciences, CDER, FDA
Jacqueline Corrigan-Curay, Principal Deputy Center Director, CDER, FDA

CTTI

Clinical Trials Transformation Initiative

Hybrid Public Workshop on AI in Drug and Biological Product Development

Hybrid Public Workshop on AI in Drug and Biological Product Development

Hybrid Public Workshop on AI in Drug and Biological Product Development

Hybrid Public Workshop Resources:

Recent News Feed